Publications by authors named "Suzanne McCarthy"

Introduction: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition, which initially presents in childhood. While prescribing trends for treating ADHD have been previously examined in Ireland's paediatric population, off-label prescribing of ADHD medication has yet to be studied.

Aim: We aimed to describe ADHD medication prescribing and off-label prescribing of ADHD medication in Ireland.

View Article and Find Full Text PDF

Background: Adoption of Human Factors (HF) principles to healthcare can help to jointly optimise work systems performance and human wellbeing. A recent systematic review identified a lack of formal patient safety (PS) and HF education in undergraduate healthcare curricula. To address this gap, qualitative research is needed to explore faculty and student perspectives, offering a deeper understanding of current educational practices and potential areas for development.

View Article and Find Full Text PDF

Background: Patients in intensive care units (ICUs) are susceptible to medication errors (MEs) for many reasons, including the complexity and intensity of care. Little is known about patient safety culture, its relationship to medication safety, and ME prevention strategies used in ICUs. This study explored the attitudes of healthcare professionals (HCPs) working in ICUs or within medication safety towards patient safety culture, medication safety, and factors influencing implementation of ME prevention strategies in ICUs across Europe.

View Article and Find Full Text PDF

Antipsychotic prescribing trends vary internationally, albeit off-label use remains high (i.e., target symptoms).

View Article and Find Full Text PDF

Objectives: Medication errors (MEs) are a leading cause of morbidity and mortality in the healthcare system. Patients admitted to intensive care units (ICUs) are potentially more susceptible to MEs due to severity of illness, the complexity of treatments they receive and the challenging nature of the ICU setting. The European Association of Hospital Pharmacists established a Special Interest Group (SIG) to undertake a programme of work to develop and prioritise recommendations to support medication safety improvement in ICUs across Europe.

View Article and Find Full Text PDF

Objective: Short-term RCTs have demonstrated that MPH-treatment significantly reduces ADHD-symptoms, but is also associated with adverse events, including sleep problems. However, data on long-term effects of MPH on sleep remain limited.

Methods: We performed a 2-year naturalistic prospective pharmacovigilance multicentre study.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the long-term safety of methylphenidate (MPH), particularly regarding its impact on pubertal maturation and bone age.
  • Participants from a two-year observational study were compared across three groups: those on MPH, those not on MPH, and a control group without ADHD.
  • Results showed no differences in sexual maturation between medicated and unmedicated ADHD groups, and while there was slight bone maturation acceleration in the medicated group, their predicted adult height remained stable, indicating no long-term safety concerns with MPH.
View Article and Find Full Text PDF

Introduction: Deprescribing is a strategy for reducing the use of potentially inappropriate medications for older adults. Limited evidence exists on the development of strategies to support healthcare professionals (HCPs) deprescribing for frail older adults in long-term care (LTC).

Objective: To design an implementation strategy, informed by theory, behavioural science and consensus from HCPs, which facilitates deprescribing in LTC.

View Article and Find Full Text PDF

Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD in children and adolescents in many countries. Although many randomised controlled trials support short-term efficacy, tolerability, and safety, data on long-term safety and tolerability are scarce. The aim of this study was to investigate the safety of methylphenidate over a 2-year period in relation to growth and development, psychiatric health, neurological health, and cardiovascular function in children and adolescents.

View Article and Find Full Text PDF

Introduction: The prevalence of polypharmacy increases with age, increasing the exposure of older adults to potentially inappropriate medications (PIMs). Deprescribing has been shown to reduce PIMs for older residents in long-term care; however, deprescribing is not universally implemented. This study aims to identify the barriers and enablers to deprescribing in Irish long-term care facilities from the healthcare professionals' (HCPs) perspective.

View Article and Find Full Text PDF

Introduction: Deprescribing is associated with positive health outcomes for older adults in long-term care (LTC), however deprescribing is not universally implemented.

Objective: The primary aim of this study was to estimate the prevalence of potentially inappropriate medications (PIMs) prescribed to frail older adults in Irish long-term care facilities (LTCFs), as identified by the Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy, version 2 (STOPPFrail v2).

Methods: A retrospective chart review was conducted in two publicly funded LTCFs in Ireland.

View Article and Find Full Text PDF

Background: With the advent of "shared regulation" over a decade ago in healthcare to allow for greater public input, the Pharmaceutical Society of Ireland (PSI) shed its professional leadership role. Since then there has been no unified voice for the profession of pharmacy in Ireland, which is in stark contrast to other jurisdictions and allied healthcare professions, where both public and practitioner are catered for in separate entities. This is an issue which has received little academic scrutiny thus far, and therefore this study provides a unique opportunity for stakeholders to submit their views.

View Article and Find Full Text PDF

Introduction: older adults are at risk of adverse outcomes due to a high prevalence of polypharmacy and potentially inappropriate medications (PIMs). Deprescribing interventions have been demonstrated to reduce polypharmacy and PIMs. However, deprescribing is not performed routinely in long-term care facilities (LTCFs).

View Article and Find Full Text PDF

Dysphagia affects swallowing not only of food and drink, but also of orally administered medications. Altering solid or liquid dose formulations renders administration unlicensed and may have adverse effects. Medication administration in patients with dysphagia necessitates a multidisciplinary approach with no one profession holding all necessary expertise.

View Article and Find Full Text PDF

Background: Misconceptions about ADHD stigmatize affected people, reduce credibility of providers, and prevent/delay treatment. To challenge misconceptions, we curated findings with strong evidence base.

Methods: We reviewed studies with more than 2000 participants or meta-analyses from five or more studies or 2000 or more participants.

View Article and Find Full Text PDF
Article Synopsis
  • Methylphenidate (MPH) is a common ADHD treatment, but there are worries about its effects on growth over time.
  • A meta-analysis of 18 studies found that long-term MPH use is linked to small but significant decreases in height and weight in children with ADHD.
  • The study suggests that while MPH may affect growth, the overall clinical impact appears minimal, and more extensive research is needed to understand its long-term effects.
View Article and Find Full Text PDF
Article Synopsis
  • Methylphenidate (MPH) is the most common long-term medication for children with ADHD, raising concerns about potential negative neurological and psychiatric effects.
  • A study using a "traffic light" system categorized the evidence on long-term MPH treatment, noting some potential risks like psychosis and tics, but also benefits like reduced depression and suicide rates.
  • There is a call for more research focusing on specific neuropsychiatric outcomes, particularly comparing long-term MPH treatment to shorter or non-pharmacological options, especially in vulnerable groups like preschoolers and adolescents prone to substance misuse.
View Article and Find Full Text PDF

Background: Concerns have been raised over the safety of methylphenidate (MPH), with regard to adverse effects on growth and blood pressure. Our study investigates whether, and to what extent, methylphenidate use in boys with ADHD is associated with having low body mass index (BMI), having low height, and increased systolic and diastolic blood pressure.

Methods: Data used for this study stem from the German KiGGS dataset.

View Article and Find Full Text PDF

Background: Patients frequently encounter difficulty understanding their prescription drug labels. This problem is more common in patients with limited health literacy (HL). Patients are not always counselled on their medicines by their doctor or pharmacist, therefore this label can be an important source of information.

View Article and Find Full Text PDF

There are negative effects to inappropriate use of benzodiazepines, yet the percentage of young people in Ireland experimenting with benzodiazepines has increased. There is a paucity of research about why Irish young people misuse benzodiazepines. In this study, people between 18 and 25 years attending substance misuse services in the south of Ireland (N = 13) were interviewed in a semi-structured style between June 2012 and April 2013.

View Article and Find Full Text PDF

Objectives: Fever is a common symptom of mostly benign illness in young children, yet concerning for parents. The aim of this study was to describe parental knowledge, attitudes and beliefs regarding fever in children aged ≤5 years of age.

Design: A cross-sectional study using a previously validated questionnaire.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the cardiovascular effects of ADHD medications (methylphenidate, amphetamines, and atomoxetine) on young patients by conducting a systematic review and meta-analysis.
  • It included data from 18 clinical trials, encompassing over 5,800 children and adolescents, and analyzed changes in blood pressure and heart rate.
  • Findings indicated a statistically significant increase in systolic blood pressure after treatment, highlighting potential concerns for cardiovascular health in patients using these medications.
View Article and Find Full Text PDF

Since the publication of To Err Is Human: Building a Safer Health System in 1999, there has been much research conducted into the epidemiology, nature and causes of medication errors in children, from prescribing and supply to administration. It is reassuring to see growing evidence of improving medication safety in children; however, based on media reports, it can be seen that serious and fatal medication errors still occur. This critical opinion article examines the problem of medication errors in children and provides recommendations for research, training of healthcare professionals and a culture shift towards dealing with medication errors.

View Article and Find Full Text PDF